In order to broaden the medical horizons of our teachers and students and to broaden their thinking on medical-industrial integration, the Education Department of China-Japan Friendship Hospital and the Center for Translational Engineering in Biomedicine (CTEIB) of CUHK jointly organized a series of lectures on medical science and technology.
On the afternoon of April 23, 2025, the Center for Translational Biomedical Engineering Research invited Mr. Ma Liang, Deputy Director of the Department of Laboratory Medicine of China-Japan Friendship Hospital, to give a lecture titled “Gene Methylation and Early Cancer Screening” to the students and teachers of the university. Mr. Ma introduced the technical bottlenecks faced by traditional screening methods: imaging is difficult to capture millimeter-sized lesions, tissue biopsy has invasive risks, and tumor markers have the defect of insufficient sensitivity. Gene methylation testing, on the other hand, advances cancer screening to the molecular diagnostic level by capturing the epigenetic characteristics of circulating tumor DNA in blood, urine and other body fluids. Gene methylation, as a core mechanism of epigenetic regulation, is rewriting the technical landscape of early cancer screening and driving cancer prevention and control into a new era of precision medicine.
Liang Ma, M.D., researcher, deputy director of the Department of Laboratory Medicine at China-Japan Friendship Hospital, visiting scholar at Baylor College of Medicine, and tutor of master's degree students at Peking Union Medical College and Peking University School of Medicine. He has published more than 100 papers in domestic and international journals, and has presided over 16 projects, including 3 National Natural Science Foundation of China (NSFC) projects. He is the associate editor of three monographs and has won the second prize of Beijing Scientific and Technological Progress.
Main Academic Affiliations
He is the executive member of Chinese Society of Integrative Medicine (CSIM) and the chairman of Molecular Diagnostic Committee, the chairman of Beijing Society of Integrative Medicine (BSIM) and Precision Medicine Committee, the vice chairman of Chinese Geriatrics Association (CGA), the editorial board member of Chinese Journal of Laboratory Medicine, and the member of Molecular Diagnostic Group of Chinese Society of Laboratory Medicine (CSPLM).
Organizer: Beijing University of Chemical Technology - China-Japan Friendship Hospital Biomedical Translational Engineering Research Center, China-Japan Friendship Hospital Education Department
Organizer: China-Japan Friendship Hospital Education Department Party Branch, China-Japan Friendship Medical College Student Union